NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫療保健人工智慧市場預測(2021年∼2026年)

Healthcare Artificial Intelligence Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023157
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
醫療保健人工智慧市場預測(2021年∼2026年) Healthcare Artificial Intelligence Market - Forecasts from 2021 to 2026
出版日期: 2021年07月07日內容資訊: 英文 118 Pages
簡介

全球醫療保健人工智能市場規模在2019年估算為34億4,100萬美元。2026年達到362億2,200萬美元,今後市場在2019年∼2026年的預測期間內,預計將以39.97%的年複合成長率成長。這個市場成長的主要因素有慢性疾病數增加,可以使用的醫療設施減少。

本報告提供全球醫療保健人工智能市場的相關調查,提供市場動態,市場分析,競爭環境與分析,企業簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶談判力
    • 買方議價能力
    • 新加入企業的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 醫療保健人工智能市場分析:各報價環

  • 簡介
  • 硬體設備
  • 軟體
  • 服務

第6章 醫療保健人工智能市場分析:各應用領域

  • 簡介
  • 影像診斷
  • 精密醫療
  • 生活方式的管理和監視
  • 虛擬助手
  • 穿戴式設備
  • 住院治療和醫院管理
  • 藥物研發
  • 研究
  • 其他

第7章 醫療保健人工智能市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東及非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第8章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第9章 企業簡介

  • Caption Health, Inc.
  • Intel Corporation
  • NVIDIA Corporation
  • Google
  • IBM Watson Health
  • Enlitic, Inc.
  • Lumiata
  • AiCure, LLC
  • Butterfly Network, Inc.
  • iCarbon X
目錄
Product Code: KSI061610978

The healthcare artificial intelligence market is projected to grow at a CAGR of 39.97% to reach US$36.222 billion by 2026 from US$3.441 billion in 2019. Artificial Intelligence essentially uses machine learning algorithms and deep learning to gather and process data and furnish it to the end-user. The foremost am of using healthcare artificial intelligence is to scrutinize relationships between prevention techniques and patient results. It is thus used to analyze a chunk of data through Electronic Health Records to prevent disease.

A major reason for the growth of this market is the increase in the number of chronic diseases and fewer health care facilities available.

According to the World Economic Forum report, "One in three adults worldwide has multiple chronic conditions: cardiovascular disease alongside diabetes, depression as well as cancer, or a combination of three, four, or even five or six diseases at the same time. NCDs represent more than half the global burden of diseases.

With the spread of such chronic diseases, globally, the health care industry has recognized the importance of healthcare artificial intelligence.

According to the World Health Organization estimates, there is a shortage of 4.3 million health workers including physicians, nurses, etc, then required, globally. Not only developing countries, but developed countries are also facing a shortage of doctors. According to OECD, "Across lower-middle and low-income Asia-Pacific countries, there is one doctor per 1 000 population, whereas a slightly higher number of doctors - 1.2 per 1 000 population - is reported in upper-middle-income countries." Also, the WHO findings suggest that the number of health workers across Europe is insufficient to meet future health requirements. The infection rate and chronic disease in Africa have risen more than double. All this has raised the need for getting such diseases diagnosed at an early stage and get them treated. Artificial Intelligence will help to monitor and diagnose the patient status efficiently and effectively and will also enable efficient follow-ups.

The technological advances and funding by both the private and public sectors are expected to drive the demand for this market in the forecast period.

There have been numerous technological advances in the field of Artificial Intelligence, globally. Many pharmaceutical companies are constantly working on up-gradation. Many health care artificial intelligence startups are encouraged across the world. Talking about Asia, in China, many startups are benefited from the government's strategic development plans. The Chinese government is constantly promoting private-public partnerships. Recently, a Chinese artificial intelligence health care startup synyi raised US $ 36.3 million. Similarly, icarbonX received funding of US$ 200 million from various investors to expand its scope of advanced artificial intelligence to cure diseases. The government of India is also funding the various AI programs and has also collaborated with the Ministry of Electronics and Information Technology (MeitY), the National E-Governance Division (NeGD), and the National Association of Software and Service Companies (NASSCOM) to build the AI healthcare future. North American countries have also invested a lot of funds into the healthcare AI market. According to WHO, the US holds the largest share in the AI healthcare market in North America. The usage of Big Data in the healthcare industry has also increased. In South America, many startups have been launched in Brazil and Argentina. Cloud platforms and robots are also widely used in the continent. The global technology revolution is at pace, Electronic health record machines are enhancing, the global health care AI market is expected to flourish.

The outbreak of COVID-19 is anticipated to fuel the growth of this market.

According to the world meter, the total number of COVID-19 cases is more than 17.9 crores, and 38.7 lakh people have died from the COVID-19 outbreak, as of June 2021. The third wave of the novel coronavirus seems to be inevitable. The Healthcare Artificial Intelligence market has seen an upward trend recently. It has helped in the identification of disease clusters. It is also widely used in monitoring cases and diagnoses. Artificial Intelligence also helped in the development of drugs and vaccines required to mitigate the effect of the virus. More developments are required in the industry for carrying out diagnoses and tests.

Artificial Intelligence Health care is expected to add value in various administrative and operational clinics. It is also expected to promote social distancing by reducing human contact and protecting public and health care staff by minimizing the time spent on claim processing.

Due to the surge of COVID-19, many AI-POWERED cameras are deployed in Singapore to reduce the need for the workforce required to check the one-to-one temperature. COVID-19 has surely moved people to focus on their personal health and adopt technologically driven health care methods.

Market Segmentation:

  • By Application

Medical Imaging and Diagnostics

Precision Medicines

Lifestyle Management and Monitoring

Virtual Assistant

Wearables

Impatient Care and Hospital Management

Drug Discovery and Development

Research

  • By offering

Hardware

Software

Services

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • UK
  • Germany
  • France
  • Others

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Healthcare Artificial Intelligence Market Analysis, by Offering

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. Healthcare Artificial Intelligence Market Analysis, by Application

  • 6.1. Introduction
  • 6.2. Medical Imaging and Diagnostics
  • 6.3. Precision Medicine
  • 6.4. Lifestyle Management and Monitoring
  • 6.5. Virtual Assistant
  • 6.6. Wearables
  • 6.7. Inpatient Care and Hospital Management
  • 6.8. Drug Discovery and Development
  • 6.9. Research
  • 6.10. Others

7. Healthcare Artificial Intelligence Market Analysis, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. UK
    • 7.4.4. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. Caption Health, Inc.
  • 9.2. Intel Corporation
  • 9.3. NVIDIA Corporation
  • 9.4. Google
  • 9.5. IBM Watson Health
  • 9.6. Enlitic, Inc.
  • 9.7. Lumiata
  • 9.8. AiCure, LLC
  • 9.9. Butterfly Network, Inc.
  • 9.10. iCarbon X